CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
Haruka Otake, Satohiro Matsumoto, Hirosato Mashima
Intest Res. 2022;20(4):464-474.   Published online March 31, 2022
DOI: https://doi.org/10.5217/ir.2021.00139

Excel Download

Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
Intestinal Research. 2022;20(4):464-474   Crossref logo
Link1 Link2 Link3

Long-Term Prognosis of Japanese Patients with Crohn’s Disease Treated by Switching Anti-Tumor Necrosis Factor-α Antibodies
Inflammatory Intestinal Diseases. 2019;5(1):11-19   Crossref logo
Link1 Link2

Long-term prognosis of Japanese patients with biologic-naïve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
Intestinal Research. 2019;17(1):94-106   Crossref logo
Link1 Link2 Link3

Is a Protective Stoma Mandatory in Anti–Tumor Necrosis Factor–Treated Crohn’s Disease Patients Undergoing Surgery?
Gastroenterology. 2022;   Crossref logo
Link1 Link2

Anti–Tumor Necrosis Factor Antibodies for Prevention of Crohn’s Disease Recurrence After Surgery: More Than a Hope
Clinical Gastroenterology and Hepatology. 2015;13(10):1856   Crossref logo
Link1 Link2

Ultrasound Elasticity Imaging Predicts Therapeutic Outcome in Patients with Crohn’s Disease Treated with Anti-Tumor Necrosis Factor Antibodies
Gastroenterology. 2017;152(5):S606   Crossref logo
Link1 Link2

OC.08.5: Ultrasound Elasticity Imaging Predicts Therapeutic Outcome in Patients with Crohn’S Disease Treated with Anti-Tumor Necrosis Factor Antibodies
Digestive and Liver Disease. 2017;49:e98   Crossref logo
Link1 Link2

Long-Term Partial Remission of AutoImmune Thrombocytopenia in a Patient Treated with the Anti-Tumor Necrosis Factor-Alpha Antibody Infliximab for Refractory Fistulizing Crohn’s Disease
Digestion. 2008;78(4):195-200   Crossref logo
Link1 Link2

Long-Term Efficacy of Anti-Tumor Necrosis Factor Agents in Pediatric Luminal Crohn's Disease: A Systematic Review of Real-World Evidence Studies
Pediatric Gastroenterology, Hepatology & Nutrition. 2020;23(2):121   Crossref logo
Link1 Link2 Link3

Anti–Tumor Necrosis Factor Therapy in Crohn's Disease: More Information and More Questions About the Long Term
Clinical Gastroenterology and Hepatology. 2010;8(7):556-558   Crossref logo
Link1 Link2